SP 24
Essential molecular characterization of AML patients
Mehmet Yilmaz
Lido
2164
Vezesque se leu este artigo
1043
Total PDF
1121
Total HTML
| Ano/Mês | Html | Total | |
|---|---|---|---|
| 2025 6 | 14 | 5 | 19 |
| 2025 5 | 47 | 15 | 62 |
| 2025 4 | 43 | 13 | 56 |
| 2025 3 | 49 | 11 | 60 |
| 2025 2 | 42 | 8 | 50 |
| 2025 1 | 35 | 21 | 56 |
| 2024 12 | 19 | 12 | 31 |
| 2024 11 | 32 | 20 | 52 |
| 2024 10 | 24 | 19 | 43 |
| 2024 9 | 43 | 18 | 61 |
| 2024 8 | 37 | 23 | 60 |
| 2024 7 | 28 | 20 | 48 |
| 2024 6 | 35 | 24 | 59 |
| 2024 5 | 31 | 20 | 51 |
| 2024 4 | 29 | 15 | 44 |
| 2024 3 | 22 | 17 | 39 |
| 2024 2 | 18 | 18 | 36 |
| 2024 1 | 18 | 25 | 43 |
| 2023 12 | 16 | 27 | 43 |
| 2023 11 | 32 | 36 | 68 |
| 2023 10 | 14 | 23 | 37 |
| 2023 9 | 19 | 29 | 48 |
| 2023 8 | 11 | 16 | 27 |
| 2023 7 | 13 | 9 | 22 |
| 2023 6 | 18 | 17 | 35 |
| 2023 5 | 22 | 23 | 45 |
| 2023 4 | 12 | 6 | 18 |
| 2023 3 | 10 | 14 | 24 |
| 2023 2 | 9 | 7 | 16 |
| 2023 1 | 10 | 5 | 15 |
| 2022 12 | 14 | 18 | 32 |
| 2022 11 | 12 | 15 | 27 |
| 2022 10 | 18 | 15 | 33 |
| 2022 9 | 15 | 23 | 38 |
| 2022 8 | 21 | 25 | 46 |
| 2022 7 | 8 | 20 | 28 |
| 2022 6 | 9 | 20 | 29 |
| 2022 5 | 9 | 17 | 26 |
| 2022 4 | 10 | 19 | 29 |
| 2022 3 | 11 | 11 | 22 |
| 2022 2 | 14 | 18 | 32 |
| 2021 1 | 9 | 23 | 32 |
| 2021 12 | 10 | 28 | 38 |
| 2021 11 | 15 | 25 | 40 |
| 2021 10 | 17 | 22 | 39 |
| 2021 9 | 22 | 17 | 39 |
| 2021 8 | 15 | 25 | 40 |
| 2021 7 | 12 | 25 | 37 |
| 2021 6 | 21 | 25 | 46 |
| 2021 5 | 24 | 35 | 59 |
| 2021 4 | 26 | 29 | 55 |
| 2021 3 | 18 | 25 | 43 |
| 2021 2 | 12 | 12 | 24 |
| 2020 1 | 13 | 14 | 27 |
| 2020 12 | 6 | 12 | 18 |
| 2020 11 | 8 | 9 | 17 |
Mostrar tudo
